Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF1) receptor antagonists

被引：15

作者：

Saito, Tetsuji ^{[1
]}

Obitsu, Tetsuo ^{[1
]}

Kohno, Hiroshi ^{[1
]}

Sugimoto, Isamu ^{[1
]}

Matsushita, Takeshi ^{[1
]}

Nishiyama, Taihei ^{[1
]}

Hirota, Tomoko ^{[1
]}

Takeda, Hiroyuki ^{[1
]}

Matsumura, Naoya ^{[1
]}

Ueno, Sonoko ^{[1
]}

Kishi, Akihiro ^{[1
]}

Kagamiishi, Yoshifumi ^{[1
]}

Nakai, Hisao ^{[1
]}

Takaoka, Yoshikazu ^{[1
]}

机构：

[1] Ono Pharmaceut Co Ltd, Minase Res Inst, Mishima, Osaka 6188585, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2012年 / 20卷 / 02期

关键词：

Corticotropin-releasing factor 1 receptor; Antagonist; MAJOR DEPRESSION; HORMONE; ANXIETY; DMP696; DERIVATIVES; R121919; SYSTEM;

D O I：

10.1016/j.bmc.2011.11.015

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

To identify structurally novel corticotropin-releasing factor 1 (CRF1) receptor antagonists, a series of bicyclic core analogs pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f]triazin-4(3H)-ones, which were designed based on a monocyclic core antagonist, was synthesized and evaluated. Among the compounds tested, 2-difluoromethoxy-4-methylpyridin-5-yl analog 27 was found to show efficacy in a dose-dependent manner in an elevated plus maze test in rats. The discovery process and structure-activity relationship is presented. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：1122 / 1138

页数：17

共 50 条

[21] Discovery of non-peptide corticotropin-releasing factor1 (CRF1) receptor antagonists as novel psychotherapeutic agents with potential utility in depression and anxiety-related disorders
Grigoriadis, D. E.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S45 - S45
[22] 8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: Selective and Centrally Active Corticotropin-Releasing Factor Receptor-1 (CRF1) Antagonists
Gilligan, Paul J.
He, Liqi
Clarke, Todd
Tivitmahaisoon, Parcharee
Lelas, Snjezana
Li, Yu-Wen
Heman, Karen
Fitzgerald, Lawrence
Miller, Keith
Zhang, Ge
Marshall, Anne
Krause, Carol
McElroy, John
Ward, Kathyrn
Shen, Helen
Wong, Harvey
Grossman, Scott
Nemeth, Gregory
Zaczek, Robert
Arneric, Stephen P.
Hartig, Paul
Robertson, David W.
Trainor, George
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) : 3073 - 3083
[23] Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinases
Fink, Brian E.
Norris, Derek
Mastalerz, Harold
Chen, Ping
Goyal, Bindu
Zhao, Yufen
Kim, Soong-Hoon
Vite, Gregory D.
Lee, Francis Y.
Zhang, Hongjian
Oppenheimer, Simone
Tokarski, John S.
Wong, Tai W.
Gavai, Ashvinikumar V.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 781 - 785
[24] Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitors
Bhide, Rajeev S.
Neels, James
Qin, Lan-Ying
Ruan, Zheming
Stachura, Sylwia
Weigelt, Carolyn
Sack, John S.
Stefanski, Kevin
Gu, Xiaomei
Xie, Jenny H.
Goldstine, Christine B.
Skala, Stacey
Pedicord, Donna L.
Ruepp, Stefan
Dhar, T. G. Murali
Carter, Percy H.
Salter-Cid, Luisa M.
Poss, Michael A.
Davies, Paul
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (17) : 4256 - 4260
[25] Proton- and halogen-induced cyclizations of 2-(3-butenyl)quinazolin-4(3H)-ones in the synthesis of pyrrolo[2,1-b]- and pyrrolo[1,2-a]quinazolinone derivatives
Vaskevych, Ruslan I. I.
Savinchuk, Nataliia O. O.
Vaskevych, Alla I. I.
Rusanov, Eduard B. B.
Bylina, Denys V. V.
Kyrylchuk, Andrii A. A.
Vovk, Mykhailo V. V.
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2023, 60 (03) : 431 - 448
[26] Recent Advances in Imidazo[5,1-f][1,2,4]triazin-4(3H)-ones Chemistry: An Overview of the Synthetic Routes to Vardenafil and Its Analogues
Gouda, Moustafa A.
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2018, 55 (03) : 564 - 585
[27] Metal Free Formation of Various 3-lodo-1H-pyrrolo[3′,2′:4,5]imidazo-[1,2-a]pyridines and [1,2-b]Pyridazines and Their Further Functionalization
Tber, Z.
Hiebel, M. -A.
El Hakmaoui, A.
Akssira, M.
Guillaumet, G.
Berteina-Raboin, S.
JOURNAL OF ORGANIC CHEMISTRY, 2015, 80 (13): : 6564 - 6573
[28] 7-ISOBUTYL-5-METHYL-2-PHENYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(3H)-ONE
MURRAYRUST, P
MURRAYRUST, J
OXFORD, AW
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1982, 38 (OCT): : 2692 - 2693
[29] Synthesis and structure-activity relationships of pyrido[3,2-b] pyrazin-3(4H)-ones and pteridin-7(8H)-ones as corticotropin-releasing factor-1 receptor antagonists
Dzierba, Carolyn D.
Sielecki, Thais M.
Arvanitis, Argyrios G.
Galka, Amy
Johnson, Tricia L.
Takvorian, Amy G.
Rafalski, Maria
Kasireddy-Polam, Padmaja
Vig, Shikha
Dasgupta, Bireshwar
Zhang, Ge
Molski, Thaddeus F.
Wong, Harvey
Zaczek, Robert C.
Lodge, Nicholas J.
Combs, Andrew P.
Gilligan, Paul J.
Trainor, George L.
Bronson, Joanne J.
Macor, John E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 4986 - 4989
[30] Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonists
Kojima, Takuto
Mochizuki, Michiyo
Takai, Takafumi
Hoashi, Yasutaka
Morimoto, Sachie
Seto, Masaki
Nakamura, Minoru
Kobayashi, Katsumi
Sako, Yuu
Tanaka, Maiko
Kanzaki, Naoyuki
Kosugi, Yohei
Yano, Takahiko
Aso, Kazuyoshi
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (09) : 2229 - 2250

← 1 2 3 4 5 →